BioGaia
98.50 SEK
-0.20 %
Less than 1K followers
BIOG B
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.20 %
-2.38 %
-5.38 %
-4.65 %
-11.97 %
-8.37 %
+11.61 %
+0.31 %
+1,286.68 %
BioGaia is a biotechnology company operating in the pharmaceutical industry and focuses on the development, manufacturing and distribution of probiotics for health and well-being. The company's products are aimed at individuals and healthcare institutions. The business is global with a primary presence in Europe, North America and Asia. BioGaia was founded in 1990 and is headquartered in Stockholm.
Read moreMarket cap
9.96B SEK
Turnover
22.4M SEK
Revenue
1.42B
EBIT %
29.76 %
P/E
28.3
Dividend yield-%
7.01 %
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12/2
2026
Annual report '25
7/5
2026
General meeting '26
7/5
2026
Interim report Q1'26
All
Webcasts
Press releases
ShowingAll content types
BioGaia AB: Delårsredogörelse januari - september 2025
BioGaia AB: Interim Management Statement January - September 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
